TD-165 is primarily utilized in the field of medicinal chemistry as a potential therapeutic agent. It has been studied for its role in targeting specific biological pathways, particularly in the treatment of certain types of cancers. The compound exhibits properties that make it a candidate for inhibiting the growth of tumor cells by interfering with key cellular processes. Additionally, TD-165 is being explored for its potential in modulating immune responses, which could be beneficial in developing treatments for autoimmune diseases or enhancing the efficacy of immunotherapies. Its application in preclinical research underscores its significance in advancing drug discovery and development efforts.